Eric Joseph Daniels
CIK: 0001892943
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Apr 20, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectRestricted Stock Units
20K shares- - Apr 20, 2026PSTV
PLUS THERAPEUTICS, INC.
Award(A)DirectStock Option (Right to Buy)
20K shares- - Apr 1, 2026KPRX
KIORA PHARMACEUTICALS INC
Tax Payment(F)Direct929 shares at avg. $1.95$2K - Mar 6, 2026KPRX
KIORA PHARMACEUTICALS INC
Award(A)Direct6.5K shares- - Mar 3, 2026KPRX
KIORA PHARMACEUTICALS INC
Tax Payment(F)Direct238 shares at avg. $2.02$480.76 - Apr 1, 2025KPRX
KIORA PHARMACEUTICALS INC
Award(A)Direct7.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 20, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Restricted Stock Units | 20,000 | - | - | Direct |
| Apr 20, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award(A) Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Apr 1, 2026 | KPRX KIORA PHARMACEUTICALS INC | Tax Payment(F) | 929 | $1.95 | $1,812 | Direct |
| Mar 6, 2026 | KPRX KIORA PHARMACEUTICALS INC | Award(A) | 6,533 | - | $0 | Direct |
| Mar 3, 2026 | KPRX KIORA PHARMACEUTICALS INC | Tax Payment(F) | 238 | $2.02 | $481 | Direct |
| Apr 1, 2025 | KPRX KIORA PHARMACEUTICALS INC | Award(A) | 7,772 | - | - | Direct |
1-6 of 6 transactions
About Daniels Eric Joseph
Daniels Eric Joseph (SEC CIK 0001892943) files insider reports with the SEC as Chief Development Officer of PLUS THERAPEUTICS, INC. (PSTV) and Chief Development Officer of KIORA PHARMACEUTICALS INC (KPRX).
Signal8 holds 6 ownership filings by Daniels Eric Joseph (1 Form 3, 5 Form 4), filed between Apr 2, 2025 and Apr 22, 2026. Those filings report 6 transactions, from Apr 1, 2025 to Apr 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Daniels Eric Joseph's filings is in ENCINITAS, CA.
Recent filings by Daniels Eric Joseph
- Apr 20, 2026: Grants or awards of PSTV derivative securities (2 lines, Form 4, code A).
- Apr 1, 2026: Tax withholding of KPRX shares (Form 4, code F).
- Mar 6, 2026: Grant or award of KPRX shares (Form 4, code A).
- Mar 3, 2026: Tax withholding of KPRX shares (Form 4, code F).
- Apr 1, 2025: Grant or award of KPRX shares (Form 4, code A).
Other insiders filing for PLUS THERAPEUTICS, INC. (PSTV)
- Lenk Robert P, Director
- Petersen Greg, Director